期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 14, 期 9, 页码 1007-1020出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.2014.929500
关键词
cryo-ablation; hadron therapy; image-guided ablation technique; microwave ablation; non-small-cell lung cancer; proton therapy; radiofrequency ablation; stereotactic body radiation therapy; sublobar resection
类别
In the last 5 years, the current management of stage I non-small-cell lung cancer has been challenged due to novel surgical approaches and advances in radiation technology. The outcome after a sublobar resection is promising, especially for tumors less than 2 cm. Other treatment opportunities are available for high risk patients with comorbidity and impaired pulmonary function. Stereotactic ablative body radiotherapy is a good alternative treatment to surgery, especially in elderly and comorbid patients. However, randomized evidence comparing sublobar resection and stereotactic radiotherapy is presently lacking. The most recent development in radiotherapy is hadron therapy with a presumed reduced toxicity because of its peculiar physical and biological effects. Promising thermal and microwave ablative techniques are in development and have specific niche indications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据